S133-118

Enrolled (Passed Congress)

To extend the National Alzheimer's Project.

118th Congress Introduced Jan 30, 2023

Legislative Progress

Enrolled (Passed Congress)
Introduced Committee Passed
Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Jan 30, 2023

Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, …

Summary

What This Bill Does

This bill reauthorizes and expands the National Alzheimer's Project (NAPA), adding focus on healthy aging, risk reduction, and cognitive health promotion. It also adds new federal agencies to the advisory council.

Who Benefits and How

  • Alzheimer's patients and families benefit from continued coordinated research efforts
  • Aging Americans benefit from expanded focus on risk reduction and prevention
  • Researchers benefit from continued funding coordination
  • Diverse populations benefit from requirements for diverse clinical trial recruitment

Who Bears the Burden and How

  • HHS and participating agencies must implement expanded program
  • Additional agencies (DOJ, FEMA, SSA, OMB) join advisory council
  • No new burdens on patients or families

Key Provisions

  • Adds healthy aging and cognitive risk reduction to program goals
  • Expands advisory council to include DOJ, FEMA, SSA, OMB designees
  • Requires diverse recruitment for clinical trials
  • Promotes public-private collaboration
  • Extends authorization timeline
Model: claude-opus-4
Generated: Jan 8, 2026 04:48

Evidence Chain:

This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.

Primary Purpose

Extends and expands the National Alzheimer's Project to include risk reduction, healthy aging, and additional federal agency participation.

Policy Domains

Healthcare Aging Research

Legislative Strategy

"Expand Alzheimer's research coordination to include prevention"

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Aging

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology